These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 12491537)

  • 1. Mode of action of membrane active antimicrobial peptides.
    Shai Y
    Biopolymers; 2002; 66(4):236-48. PubMed ID: 12491537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of linear amphipathic alpha-helical antimicrobial peptides.
    Oren Z; Shai Y
    Biopolymers; 1998; 47(6):451-63. PubMed ID: 10333737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
    Brogden KA
    Nat Rev Microbiol; 2005 Mar; 3(3):238-50. PubMed ID: 15703760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceragenins: cholic acid-based mimics of antimicrobial peptides.
    Lai XZ; Feng Y; Pollard J; Chin JN; Rybak MJ; Bucki R; Epand RF; Epand RM; Savage PB
    Acc Chem Res; 2008 Oct; 41(10):1233-40. PubMed ID: 18616297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esculentin-1b(1-18)--a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli.
    Marcellini L; Borro M; Gentile G; Rinaldi AC; Stella L; Aimola P; Barra D; Mangoni ML
    FEBS J; 2009 Oct; 276(19):5647-64. PubMed ID: 19725877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphipathic, alpha-helical antimicrobial peptides.
    Tossi A; Sandri L; Giangaspero A
    Biopolymers; 2000; 55(1):4-30. PubMed ID: 10931439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli.
    Mangoni ML; Papo N; Barra D; Simmaco M; Bozzi A; Di Giulio A; Rinaldi AC
    Biochem J; 2004 Jun; 380(Pt 3):859-65. PubMed ID: 15032749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action.
    Avrahami D; Shai Y
    Biochemistry; 2003 Dec; 42(50):14946-56. PubMed ID: 14674771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria.
    Hale JD; Hancock RE
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):951-9. PubMed ID: 18039080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence and electron microscopy methods for exploring antimicrobial peptides mode(s) of action.
    Marcellini L; Giammatteo M; Aimola P; Mangoni ML
    Methods Mol Biol; 2010; 618():249-66. PubMed ID: 20094869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
    Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
    Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity.
    Mangoni ML; Papo N; Mignogna G; Andreu D; Shai Y; Barra D; Simmaco M
    Biochemistry; 2003 Dec; 42(47):14023-35. PubMed ID: 14636071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?
    Papo N; Shai Y
    Peptides; 2003 Nov; 24(11):1693-703. PubMed ID: 15019200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.
    Pag U; Oedenkoven M; Papo N; Oren Z; Shai Y; Sahl HG
    J Antimicrob Chemother; 2004 Feb; 53(2):230-9. PubMed ID: 14729742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide.
    Malina A; Shai Y
    Biochem J; 2005 Sep; 390(Pt 3):695-702. PubMed ID: 15907192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides.
    Gutsmann T; Hagge SO; David A; Roes S; Böhling A; Hammer MU; Seydel U
    J Endotoxin Res; 2005; 11(3):167-73. PubMed ID: 15949145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
    Lee DL; Hodges RS
    Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of antibacterial action of dermaseptin B2: interplay between helix-hinge-helix structure and membrane curvature strain.
    Galanth C; Abbassi F; Lequin O; Ayala-Sanmartin J; Ladram A; Nicolas P; Amiche M
    Biochemistry; 2009 Jan; 48(2):313-27. PubMed ID: 19113844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence requirements and an optimization strategy for short antimicrobial peptides.
    Hilpert K; Elliott MR; Volkmer-Engert R; Henklein P; Donini O; Zhou Q; Winkler DF; Hancock RE
    Chem Biol; 2006 Oct; 13(10):1101-7. PubMed ID: 17052614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues.
    Song YM; Park Y; Lim SS; Yang ST; Woo ER; Park IS; Lee JS; Kim JI; Hahm KS; Kim Y; Shin SY
    Biochemistry; 2005 Sep; 44(36):12094-106. PubMed ID: 16142907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.